Trihydroxycholestanoic acid
Based on 1 Customer Validation
Trihydroxycholestanoic acid is an endogenous metabolite present in Blood that can be used for the research of Zellweger Syndrome, Refsum Disease, D Bifunctional Protein Deficiency and Infantile Refsum Disease.
For research use only. We do not sell to patients.
- Purity: 99.48%
- CAS No.: 547-98-8
- Formula: C27H46O5
- Molecular Weight:450.65
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
-
HY-125731
Glycodeoxycholic acid -
HY-122141
Glycohyocholic acid -
HY-116374
Glycolithocholic acid -
HY-N1424
Glycoursodeoxycholic acid -
HY-113308
Taurolithocholic acid -
HY-14905
Uridine triacetate -
HY-N7745
Glucosylsphingosine -
HY-B0172B
Isolithocholic acid -
HY-41324
7-keto-Deoxycholic acid -
HY-41324R
7-keto-Deoxycholic acid (Standard) -
HY-B0172BR
Isolithocholic acid (Standard) -
HY-156208
C2 Adamantanyl galactosylceramide (d18:1/2:0)
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
In Vitro
Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 547-98-8
-
Appearance Solid
-
Molecular Weight 450.65
-
Formula C27H46O5
-
Color White to off-white
-
SMILES
CC(C(O)=O)CCC[C@@H](C)[C@H]1CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C
-
Synonyms
Coprocholic acid
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (269 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
References
[1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief]
[2]. Baumgartner MR, et al. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [Content Brief]
[3]. Poll-The BT, et al. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis. 1986;9(2):169-74. [Content Brief]
[4]. Rizzo C, et al. Characteristic acylcarnitine profiles in inherited defects of peroxisome biogenesis: a novel tool for screening diagnosis using tandem mass spectrometry. Pediatr Res. 2003 Jun;53(6):1013-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Trihydroxycholestanoic acid Related Classifications
HY-113335 Related Classifications
Powered by Bioz